Table 4.
Changes in disease stages from anatomic stage groups to prognostic stage groups (N = 7458)
| AJCC8 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| IA | IB | IIA | II | IIIA | IIIB | IIIC | Anonymous | Total | ||
| AJCC7 | IA |
647
(22.5%) |
1455 (50.7%) |
714 (24.9%) |
0 | 0 | 0 | 0 | 54 (1.9%) |
2870 (38.5) |
| IB | 20 (19.2%) |
48
(46.2%) |
34 (32.6%) |
1 (1.0%) |
0 | 0 | 0 | 1 (1.0%) |
104 (1.4%) |
|
| IIA | 0 | 193 (8.9%) |
276
(12.7%) |
970 (44.7%) |
732 (33.7%) |
0 | 0 | 0 | 2171 (29.1%) |
|
| IIB | 0 | 68 (5.6%) |
4 (0.3%) |
50
(4.1%) |
278 (22.8%) |
80 (6.6%) |
296 (24.3%) |
441 (36.3%) |
1217 (16.3%) |
|
| IIIA | 0 | 33 (5.0%) |
1 (0.2%) |
22 (3.4%) |
214
(32.7%) |
150 (22.9%) |
233 (35.6%) |
1 (0.2%) |
654 (8.8%) |
|
| IIIB | 0 | 0 | 0 | 0 | 0 |
4
(5.%) |
74 (94.9%) |
0 | 78 (1.0%) |
|
| IIIC | 0 | 0 | 0 | 0 | 0 | 30 (8.2%) |
334
(91.8%) |
0 | 364 (4.9%) |
|
| Total | 667 (8.9%) |
1797 (24.1%) |
1029 (13.8%) |
1043 (14.0%) |
1224 (16.4%) |
264 (3.5%) |
937 (12.6%) |
497 (6.7%) |
7458 | |